Description: This session is intended to provide an update on past, current, and future studies done by the SOA GLTD Experience Committee. This includes an update on the ongoing Group LTD Incidence Survey including the nature of the study, goals, timelines, data submissions, and current status.

Description: When actuaries and consultants evaluate various pharmaceuticals for inclusion in an employer’s benefits offering, it can be commonplace to look at the advertised list price, or WAC (wholesale acquisition cost), between products and use that as a primary driver in the evaluation process.

Description: As health insurance self-funding becomes more popular among smaller group sizes, risk is evolving for the MGUs, stop loss writers, and reinsurers that cover them. Assessing more small groups at lower attachment points means rethinking traditional stop loss underwriting techniques.

Description: This game-style session will test your knowledge on several topics related to Supplemental Benefits. Our panel of carrier representatives will offer a range of industry perspectives, and our live studio audience will learn new industry insights and have some fun!

Description: Our panel of experts will explore 'Blue Zone' communities, the common denominators slowing the aging process and the potential impacts these initiatives could have on disability and long-term care insurance.